Mangrove Partners Cuts Stake in Biota Pharmaceuticals

Nathaniel August‘s Mangrove Partners has reported, in a recent filing with the SEC, that it no longer is an owner of more than 5% of the common stock of Biota Pharmaceuticals Inc (NASDAQ:BOTA). Mangrove Partners now owns only 176 shares of the company.


Disclosure: none

Recommended reading:

Jim Simons’ Latest Strategy is ‘Out With the New, In With the Old’

Ray Dalio, Bridgewater Make Micron New Top Dog, Love Tech Blue Chips

BlueMountain Unhappy With Chatham Takeover Rejection